Skip to content

Advertisement

  • Poster presentation
  • Open Access

National rare diseases registry in Spain: pilot study of the Spanish Rare Diseases Registries Research Network (SpainRDR)

  • 1,
  • 1,
  • 2,
  • 3,
  • 4,
  • 5,
  • 6,
  • 7,
  • 8,
  • 9,
  • 10,
  • 11,
  • 12,
  • 13,
  • 14,
  • 15,
  • 16,
  • 17,
  • 18 and
  • 1Email author
Orphanet Journal of Rare Diseases20149 (Suppl 1) :P5

https://doi.org/10.1186/1750-1172-9-S1-P5

  • Published:

Keywords

  • Rare Disease
  • Orphan Drug
  • Data Harmonization
  • Common Data Element
  • Insurance Card

Background

The development of a national Rare Diseases (RD) registry in Spain was launched in 2012 with the project SpainRDR, supported by the International Rare Diseases Research Consortium (IRDiRC). SpainRDR includes two different strategies: patient registries addressed to patient outcome research and population-based registries addressed to epidemiologic research, health and social planning [1]. The pilot study aims to detect the difficulties of developing the national and population-based RD registry.

Material and methods

Both comprehensive RD lists and common data elements (CDE) have been defined and harmonized with other international strategies (EPIRARE, RD-CONNECT, NIH). CDEs mainly comprise variables related to personal identification data and RD definition. RD patient information was collected from regional health databases corresponding to 2010 and 2011: electronic hospital records (discharges basic minimum dataset), mortality registry, health insurance card databases, electronic primary care clinical records, chronic renal diseases registry, orphan drugs registry, newborn screening registry and tumor registry, among others.

Results

Data representing 80.2% of the Spanish population have been initially communicated to the central data repository during the pilot study (Figure 1). A total of 824,399 RD cases have been detected. As an example, RD show 26% congenital anomalies; 19% endocrine, nutritional and metabolic diseases; 13% blood and blood-forming organs and certain disorders involving the immune mechanism; 10% diseases of the circulatory system (Figure 2). Practical problems detected in the pilot study have been discussed and fixed. Final patient recruitment has already started and it will include RD cases detected from 2010 to 2012.
Figure 1
Figure 1

Participation of Regional Health Departments in the pilot study: types of reported cases to central repository

Figure 2
Figure 2

Number of reported RD cases by ICD chapter

Conclusion

In summary, National Institute of Rare Diseases Research and Regional Health Departments of Spain are working together towards a harmonized RD patient registration. The Spanish experience could be a model for other countries with complex political and administrative structures which, in order to carry out a national RD registry, will require the standardization of criteria, data harmonization and coordination between regions.

Declarations

Acknowledgements

On behalf SpainRDR group. Financial agency: Instituto de Salud Carlos III - International Rare Diseases Research Consortium (IRDiRC). Grant no. IR11-RDR.

Authors’ Affiliations

(1)
Institute of Rare Diseases Research, Instituto de Salud Carlos III, CIBERER, Madrid, 28029, Spain
(2)
DG Salud Pública, FISABIO-Saud Pública, CIBERESP, Valencia, 46020, Spain
(3)
Subdirección de Promoción de salud y Prevención, Consejería de Sanidad, 28037 Madrid, Spain
(4)
Departamento de salud, Gobierno Vasco, Álava, Vitoria-Gasteiz, 01010, Spain
(5)
Servicio andaluz de Salud, Sevilla, 41071, Spain
(6)
DG Salud pública, Consejería de Sanidad, Oviedo, 33006, Asturias, Spain
(7)
Servei Català de la Salut, 08018 Barcelona, Spain
(8)
Consejería Sanidad y Política Social, Servicio Planificación y Financiación Sanitaria, Murcia, 30001, Spain
(9)
Scio. Pediatría, C. Hospitalario Univ. Insular Materno Infantil, Las Palmas de Gran Canaria, 35016, Spain
(10)
Servicio Epidemiología y Prevención Sanitaria, Gobierno de La Rioja, 26071, Logroño, La Rioja, Spain
(11)
Subdirección de Epidemiología, Servicio Extremeño de Salud, Mérida, 06800, Badajoz, Spain
(12)
DG Planificación y Aseguramiento, Servicio Evaluación y Acreditación Sanitaria, Zaragoza, 50017, Spain
(13)
Observatorio de Salud Pública, DG Salud Pública, Valladolid, 47071, Spain
(14)
DG Salud Pública, Drogodep. y Consumo, Consejería Sanidad y Asuntos Sociales, Toledo, 45005, Spain
(15)
DG Salut Pública i Consum, Conselleria Salut, Palma, 07010, Islas Baleares, Spain
(16)
Scio Atención Sanitaria, Consejería Sanidad y Servicios Sociales, Santander, 39009, Cantabria, Spain
(17)
Scio. Anatomía Patológica, Instituto de Investigación Biomédica de Vigo, Vigo, 36200, Pontevedra, Spain
(18)
Instituto de Salud Pública de Navarra, CIBERESP, Pamplona, 31003, Navarra, Spain

References

  1. The Spanish Rare Diseases Registries Research Network [https://spainrdr.isciii.es/en/].

Copyright

© Alonso et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement